Luis-Emilio Garcia-Perez - Eli Lilly and Company

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 57 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Resource Use and Costs of Treatment in Clinical Practice in France, Germany, and Italy

Annabel Barrett,Kristina S. Boye,Luis-Emilio Garcia-Perez,Francesco Giorgino,Bruno Guerci,Martin Fuchtenbusch,Maria Yu,Helene Sapin,Anne Dib,Elke Heitmann,Marco Orsini Federici,Jeremie Lebrec

JOURNAL OF MEDICAL ECONOMICSno. 1 (2024): 866-879

引用0浏览0WOS引用

Perte De Poids Par Statut Ménopausique Chez Les Femmes Traitées Par Tirzépatide : Analyse Post Hoc Du Programme SURMOUNT

G. Sleilaty, A. Ciudin Mihai, A. Stefanski,L.E. García-Pérez, D. Mojdami, I. Jouravskaya, S. Gurbuz, R. Taylor, J.P. Dunn

Annales d'Endocrinologieno. 5 (2024)

引用0浏览0引用

264-OR: Effect of Tirzepatide on Kidney Function in People with Excess Body Weight and Type 2 Diabetes—A Post-Hoc Analysis of the SURMOUNT-2 Trial

HIDDO L. HEERSPINK, ALLON FRIEDMAN, PETTER BJORNSTAD,DANIËL VAN RAALTE, DACHUANG CAO,LUIS-EMILIO GARCIA-PEREZ,ADAM STEFANSKI, IBRAHIM TURFANDA,MATHIJS C. BUNCK, IMANE BENABBAD, CAROLINA PIRAS DE OLIVEIRA, RYAN GRIFFIN

Diabetes（2024）

引用0浏览0引用

Body Weight Reduction in Women Treated with Tirzepatide by Menopausal Stage: A Post Hoc Analysis from the SURMOUNT Program

Andreea Ciudin Mihai,Adam Stefanski,Luis-Emilio García-Pérez,Donna Mojdami,Irina Jouravskaya,Sirel Gurbuz, Rebecca Taylor,Julia P. Dunn,Sarah Glastras

Obesity Research &amp Clinical Practiceno. 5 (2024)

引用0浏览0引用

790-P: the Effect of Tirzepatide Vs. Placebo on Changes and Shifts in BMI Category in Adults with Type 2 Diabetes—A Post Hoc Analysis of the SURMOUNT-2 Study

RODOLFO J. GALINDO, ETHAN LAZARUS, Hui Wang,LUIS-EMILIO GARCIA-PEREZ, Mingjie Zhang, G. A. Grant,Raleigh Malik

Diabetesno. Supplement_1 (2024)

引用0浏览0引用

#1701797 Waist-to-height Ratio Shifts over Time in Tirzepatide-Treated Participants – Post Hoc Analysis in SURMOUNT-1 and SURMOUNT-2

Beverly Tchang,Naveed Sattar,Julia Dunn,Xiaotian Michelle Zhang,Luis-Emilio Garcia-Perez, Hui Wang, Casey Mast,Julia Fraseur Brumm

Endocrine Practiceno. 5 (2024): S68-S69

引用0浏览0引用

Baseline Characteristics Associated with Time to Weight Plateau with Tirzepatide in SURMOUNT-1

Deborah Horn,Clare Lee,Dachuang Cao,Nadia Ahmad,Mathijs Bunck,Adam Stefanski,Luis-Emilio Garcia-Perez, Farai Chigutsa,Julia Dunn

OBESITY（2023）

引用0浏览0引用

Patients' Preferences for Antiobesity Treatment Features: A US Focus Group Study

Shraddha Shinde,Melissa Ross,Jaime Almandoz,Sarah Mulnick, Matthew Quaife, Jacob Aiello,Donna Mojdami,Luis-Emilio Garcia-Perez, Kyrian Ezendu, Emily Hankosky

OBESITY（2023）

引用0浏览0引用

Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison

Carel W le Roux,Emily R Hankosky,Duzhe Wang,Raleigh Malik,Maria Yu,Ana Hickey,Hong Kan,Mathijs C Bunck,Adam Stefanski,Luis-Emilio Garcia-Perez,Sean Wharton

Diabetes, obesity & metabolismno. 9 (2023): 2626-2633

引用1浏览0WOS引用

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Final Patient-Reported Outcomes at 24 Months

Kristina S. Boye,Jeremie Lebrec,Anne Dib,Elke Heitmann,Marco Orsini Federici,Maria Yu,Helene Sapin,Annabel Barrett,Bruno Guerci,Francesco Giorgino,Martin Fuechtenbusch,Luis-Emilio Garcia-Perez

Diabetes, obesity & metabolism/Diabetes, obesity and metabolism（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn